Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Clinical Subtype | Transcriptional Subtype | Small Molecule | Antibody | Perturbagen Target | Perturbagen Class | Perturbagen Concentration | Perturbagen Conc Unit | Biological Replicate ID | Relative Cell Count | Normalized Growth Rate Inhibition Value | Nominal Division Rate |
---|---|---|---|---|---|---|---|---|---|---|---|---|
SUM1315MO2 | TNBC | Basal B | FTase Inhibitor I | Ftase | MAPK | 13.3 | uM | 12428.167 | 0.8767 | 0.7573 | 1.0169 | |
SUM1315MO2 | TNBC | Basal B | FTase Inhibitor I | Ftase | MAPK | 66.7 | uM | 12428.167 | 0.7862 | 0.5788 | 1.0169 | |
SUM149PT | TNBC | Basal B | FTase Inhibitor I | Ftase | MAPK | 0.0000853 | uM | 10819.154 | 0.9553 | 0.9563 | 2.0680 | |
SUM149PT | TNBC | Basal B | FTase Inhibitor I | Ftase | MAPK | 0.000427 | uM | 10819.154 | 1.0031 | 1.0030 | 2.0680 | |
SUM149PT | TNBC | Basal B | FTase Inhibitor I | Ftase | MAPK | 0.00213 | uM | 10819.154 | 0.9846 | 0.9850 | 2.0680 | |
SUM149PT | TNBC | Basal B | FTase Inhibitor I | Ftase | MAPK | 0.0107 | uM | 10819.154 | 0.9980 | 0.9981 | 2.0680 | |
SUM149PT | TNBC | Basal B | FTase Inhibitor I | Ftase | MAPK | 0.0533 | uM | 10819.154 | 1.0234 | 1.0225 | 2.0680 | |
SUM149PT | TNBC | Basal B | FTase Inhibitor I | Ftase | MAPK | 0.267 | uM | 10819.154 | 0.9636 | 0.9644 | 2.0680 | |
SUM149PT | TNBC | Basal B | FTase Inhibitor I | Ftase | MAPK | 1.33 | uM | 10819.154 | 0.9393 | 0.9403 | 2.0680 | |
SUM149PT | TNBC | Basal B | FTase Inhibitor I | Ftase | MAPK | 6.67 | uM | 10819.154 | 1.0308 | 1.0296 | 2.0680 | |
SUM149PT | TNBC | Basal B | FTase Inhibitor I | Ftase | MAPK | 33.3 | uM | 10819.154 | 0.5088 | 0.4426 | 2.0680 | |
SUM149PT | TNBC | Basal B | FTase Inhibitor I | Ftase | MAPK | 0.0000853 | uM | 11937.154 | 0.9036 | 0.9214 | 2.5304 | |
SUM149PT | TNBC | Basal B | FTase Inhibitor I | Ftase | MAPK | 0.000427 | uM | 11937.154 | 0.8775 | 0.8993 | 2.5304 | |
SUM149PT | TNBC | Basal B | FTase Inhibitor I | Ftase | MAPK | 0.00213 | uM | 11937.154 | 0.9260 | 0.9402 | 2.5304 | |
SUM149PT | TNBC | Basal B | FTase Inhibitor I | Ftase | MAPK | 0.0107 | uM | 11937.154 | 0.9240 | 0.9385 | 2.5304 | |
SUM149PT | TNBC | Basal B | FTase Inhibitor I | Ftase | MAPK | 0.0533 | uM | 11937.154 | 0.9737 | 0.9790 | 2.5304 | |
SUM149PT | TNBC | Basal B | FTase Inhibitor I | Ftase | MAPK | 0.267 | uM | 11937.154 | 0.8869 | 0.9074 | 2.5304 | |
SUM149PT | TNBC | Basal B | FTase Inhibitor I | Ftase | MAPK | 1.33 | uM | 11937.154 | 0.9547 | 0.9637 | 2.5304 | |
SUM149PT | TNBC | Basal B | FTase Inhibitor I | Ftase | MAPK | 6.67 | uM | 11937.154 | 0.8820 | 0.9032 | 2.5304 | |
SUM149PT | TNBC | Basal B | FTase Inhibitor I | Ftase | MAPK | 33.3 | uM | 11937.154 | 0.2548 | 0.1651 | 2.5304 | |
SUM159PT | TNBC | Basal B | FTase Inhibitor I | Ftase | MAPK | 0.0000853 | uM | 10520.142 | 0.9820 | 0.9886 | 3.1766 | |
SUM159PT | TNBC | Basal B | FTase Inhibitor I | Ftase | MAPK | 0.000427 | uM | 10520.142 | 0.9740 | 0.9835 | 3.1766 | |
SUM159PT | TNBC | Basal B | FTase Inhibitor I | Ftase | MAPK | 0.00213 | uM | 10520.142 | 1.0569 | 1.0351 | 3.1766 | |
SUM159PT | TNBC | Basal B | FTase Inhibitor I | Ftase | MAPK | 0.0107 | uM | 10520.142 | 1.1775 | 1.1056 | 3.1766 | |
SUM159PT | TNBC | Basal B | FTase Inhibitor I | Ftase | MAPK | 0.0533 | uM | 10520.142 | 0.8501 | 0.9003 | 3.1766 |